Cargando…

A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy

Glioblastoma multiforme (GBM) and malignant gliomas are the most common primary malignant brain tumors. Temozolomide (TMZ) chemotherapy plus radiation therapy (RT), admi-mistered after debulking surgery, increased the median survival time (MST) from 12.1 months with RT alone merely to 14.6 months, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somlyai, Gábor, Kovács, Beáta Zsuzsanna, Papp, András, Somlyai, Ildikó
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377426/ https://www.ncbi.nlm.nih.gov/pubmed/37509628 http://dx.doi.org/10.3390/biomedicines11071989

Ejemplares similares

Effect of Systemic Subnormal Deuterium Level on Metabolic Syndrome Related and other Blood Parameters in Humans: A Preliminary Study
por: Somlyai, Gábor, et al.
Publicado: (2020)

Deuterium-depleted water stimulates GLUT4 translocation in the presence of insulin, which leads to decreased blood glucose concentration
por: Molnár, Miklós, et al.
Publicado: (2021)

Deuterium-depletion has no significant impact on the mutation rate of Escherichia coli, deuterium abundance therefore has a probabilistic, not deterministic effect on spontaneous mutagenesis
por: Ajibola, Walliyulahi, et al.
Publicado: (2021)

Deuterium Content of the Organic Compounds in Food Has an Impact on Tumor Growth in Mice
por: Somlyai, Gábor, et al.
Publicado: (2022)

Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer
por: Boros, László G., et al.
Publicado: (2021)

Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
por: Kovács, Beáta Zs., et al.
Publicado: (2022)

Deuterium Depleted Water Effects on Survival of Lung Cancer Patients and Expression of Kras, Bcl2, and Myc Genes in Mouse Lung
por: Gyöngyi, Zoltán, et al.
Publicado: (2013)

Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration
por: Katona, Gábor, et al.
Publicado: (2022)

Type IV Collagen Is Essential for Proper Function of Integrin-Mediated Adhesion in Drosophila Muscle Fibers
por: Kiss, András A., et al.
Publicado: (2019)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Revealing water’s secrets: deuterium depleted water
por: Goncharuk, Vladyslav V, et al.
Publicado: (2013)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic
por: Afshari, Amir R., et al.
Publicado: (2020)

Possible mediation of Cladocera species by a researcher's chest wader
por: Hajredini, Arber, et al.
Publicado: (2023)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma
por: Somlyai, Gábor, et al.
Publicado: (2017)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy
por: Pająk, Beata
Publicado: (2022)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Assessing adverse childhood experiences, social, emotional, and behavioral symptoms, and subjective health complaints among Hungarian adolescents
por: Kovács-Tóth, Beáta, et al.
Publicado: (2021)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

High metallothionein predicts poor survival in glioblastoma multiforme
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
por: Makowska, Marianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2fs2vv6e76l4si2irqqftm40or